ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 70 filers reported holding ONCOMED PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $77,000 | – | 18,701 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,400,289 | $14,653,000 | 2.28% |
| ADAMS STREET PARTNERS LLC | 1,839,730 | $6,126,000 | 1.44% |
| Iguana Healthcare Management, LLC | 400,000 | $1,332,000 | 0.75% |
| ELEMENT CAPITAL MANAGEMENT LLC | 91,059 | $303,000 | 0.06% |
| TURNER INVESTMENTS LLC | 24,783 | $83,000 | 0.06% |
| Birchview Capital, LP | 28,689 | $96,000 | 0.05% |
| Cannell & Co. | 407,741 | $1,358,000 | 0.05% |
| NJ State Employees Deferred Compensation Plan | 48,000 | $160,000 | 0.03% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 329,100 | $1,096,000 | 0.02% |
| Burt Wealth Advisors | 7,519 | $25,000 | 0.02% |